Two other pharmaceutical companies earning honors in the silver and bronze levels led to a sweep by life science companies in the Greater Boston Region.
The Massachusetts Alliance for Economic Development (MassEcon) is a private, non-profit partnership of business, industry leaders, and government dedicated to the economic growth of Massachusetts. Companies were judged on investment in facilities, job growth, and community involvement.
Cubist President and CEO Michael Bonney said, "Cubist recognizes the unique blend of resources that Massachusetts presents to employers in the life science sector: supportive and collaborative state and local government, world-class schools of higher learning and a commitment to early learning, and an unmatched talent pool. I cannot imagine a better place to start and grow a life science business."
Susan Houston, Executive Director of MassEcon, said, "Each year we are proud to confer these awards on companies that invest in Massachusetts. Cubist distinguished itself in so many areas and exemplifies what is best about Massachusetts companies."
Cubist Pharmaceuticals is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.
More Information:
www.cubist.com
((Comments on this story may be sent to newsdesk@closeupmedia.com))

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index